HealthDay on MSN4d
GLP-1 RA Use Linked to Reduced Cirrhosis Risk in MASLD, Diabetes
For patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and diabetes, glucagon-like peptide 1 ...
Science Daily8d
Key factors that impact long-term weight loss in patients prescribed GLP-1 RA medications
A new study identified key factors that can impact the long-term weight loss of patients with obesity who were prescribed injectable semaglutide or liraglutide for the treatment of type 2 diabetes or ...
Key factors identified that can impact long-term weight loss in patients with obesity prescribed GLP-1 RA medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...
Daily6d
Cleveland Clinic Study Identifies Key Factors Influencing Long-Term Weight Loss with GLP-1 RA Medications
A Cleveland Clinic study identified key factors that can impact the long-term weight loss of patients with obesity who were ...
Medscape10d
Longer Acting GLP-1 Receptor Agonists and the Potential for Improved Cardiovascular Outcomes
GLP-1: Glucagon-like peptide-1; RA: receptor agonist. ACS: Acute coronary syndrome; CAD: Coronary artery disease; CHF: Congestive heart failure; CRF: Chronic renal ...